Enrichment analysis of genes dysregulated following Rosiglitazone treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013761
TitleEnrichment analysis of genes dysregulated following Rosiglitazone treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Rosiglitazone treated cells and untreated control cells in the left sciatic nerve cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3087131
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis CuratorAliDot
CREEDS IDdrug:2672
Cell Typeleft sciatic nerve
Drug NameRosiglitazone
Organismmouse
PubChem CID77999
SMILES IDCN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
Characteristic Direction parameters
Control SamplesGSM286159, GSM286160, GSM286163, GSM286165
Perturbed SamplesGSM286431, GSM286432, GSM286433, GSM286434, GSM286436
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE11343
Gene Expression Omnibus
Rosiglitazone effect on streptozotocin-induced diabetic DBA/2J mice: perpheral sciatic nerve
26
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.